Showing results (1471-1480 of 2,232) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar ratsKristina Norrgren, Maria Sjölin, Sven Björkman, et al.Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
The diagnostic role of radioactivity in sentinel nodes in oral and oropharyngeal cancerAdorján F Kovács, Natascha Döbert, Hartmut Walendzik, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Chemoembolization using cisplatin crystals as neoadjuvant treatment of oral cancerAdorján F KovácsCancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Dose-dependent treatment benefit in high-risk melanoma patients receiving adjuvant high-dose interferon alfa-2bMichael Fluck, Darab Kamanabrou, Andrea Lippold, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Molecular and immunophenotypical characterization of progressive and regressive leukemia cell linesSiguo Hao, Xuguang Bi, Liping Su, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibodyBaiyang Wang, Marc Berger, Gregg Masters, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Radiosynoviorthesis in osteoarthritis and other disorders with concomitant synovitis in comparison to rheumatoid arthritisHarald Rau, Christian Franke, Günter Goretzki, et al.Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Effects of radiosynovectomy with p-32 colloid therapy in hemophilia and rheumatoid arthritisVictoria Ester Soroa, Mańa del Huerto Velázquez Espeche, Carlos Giannone, et al.Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Extravazation of therapeutic yttrium-90-ibritumomab tiuxetan (zevalin): a case reportGethin Williams, Matthew R Palmer, J Anthony Parker, et al.Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of diseaseEkaterina Dadachova, Tiffany Moadel, Andrew D Schweitzer, et al.Pageof 224